ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders.

Their auditors issued a going concern opinion on their December 31, 2019 financial statements, expressing substantial doubt that they could continue as an ongoing business for the next twelve months.   

$1.19  -0.04 (-3.25%)
As of 06/24/2022 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/27/2018
Outstanding shares:  23,788,962
Average volume:  284,032
Market cap:   $29,260,423
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   2.64
PS ratio:   0.00
Return on equity:   -163.42%
Net income %:   0.00%